TUYET TRUONG: Open Payments
NPI 1326611401 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$577 in 29 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $23 · 2025 $577
Food & beverage: $577
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $91 |
| Corcept Therapeutics | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Exact Sciences Corporation | 2 | $49 |
| Astellas Pharma US Inc | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| PFIZER INC. | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Novo Nordisk Inc | 2 | $38 |
Products named: JARDIANCE, Korlym, Veozah, MOUNJARO, TRELEGY ELLIPTA, AIRSUPRA, PREVNAR 20, Auvelity.
Industry payments across NY — which companies pay providers there.
